NOVAVAX INC Loss Contingency, New Claims Filed, Number
NOVAVAX INC (NVAX) had Loss Contingency, New Claims Filed, Number of 8 lawsuit as of 2024-12-28, per its 10-K filed 2025-02-27.
Financial Statements › Notes › Commitment and Contingencies › Loss Contingency
us-gaap:LossContingencyNewClaimsFiledNumber · last filed 2025-02-27
- 2024-12-28: Loss Contingency, New Claims Filed, Number 8.00 lawsuit.
- 2022-12-28: Loss Contingency, New Claims Filed, Number 8.00 lawsuit; Loss Contingency, New Claims Filed, Number as first filed 7.00 lawsuit.
| Period end | Loss Contingency, New Claims Filed, Number | Loss Contingency, New Claims Filed, Number as first filed |
|---|---|---|
| 2024-12-28 | 8.00 lawsuit 10-K · filed 2025-02-27 | |
| 2022-12-28 | 8.00 lawsuit 10-Q · filed 2024-11-12 | 7.00 lawsuit 10-Q · filed 2023-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |